EnSenSys

Curated by Signal

Developer of non-invasive screening device for viral infectious diseases

Overview

Developer of non-invasive screening device for viral infectious diseases. It utilizes hyperspectral imaging, AI, and machine learning to rapidly detect the presence or absence of pathogens in humans, animals, and the environment.

Key facts

Founded: 2020
Headquarters: Alamo, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

MyGenomeRx
Provider of a platform for genomic testing
Life Sciences TechnologyPalatine, United States
Health Heritage
Clinical decision support for personalized risk assessment for major inheritable cancers.
Life Sciences TechnologyChicago, United States
Cellogy
Stem cell-based modeling using machine learning
Life Sciences TechnologyMenlo Park, United States

About EnSenSys

What does EnSenSys do?

Developer of non-invasive screening device for viral infectious diseases.

Where is EnSenSys headquartered?

EnSenSys is headquartered in Alamo, United States.

When was EnSenSys founded?

EnSenSys was founded in 2020.

Which sector is EnSenSys in?

EnSenSys operates in Life Sciences Technology.

Who are EnSenSys's competitors?

Companies similar to EnSenSys include MyGenomeRx, Health Heritage, and Cellogy.